Bloomberg News

Roche Says Commission Extended Avastin Label to Include Xeloda

June 30, 2011

June 30 (Bloomberg) -- Roche Holding AG said the European Commission extended the Avastin metastatic breast cancer label to include combination with Xeloda, according to an e-mailed statement today.

To contact the editor responsible for this story: Simone Meier at smeier@bloomberg.net


Steve Ballmer, Power Forward
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus